Edition:
United States

Lonza Group AG (LZAGF.PK)

LZAGF.PK on OTC Markets Group

225.74USD
--
Change (% chg)

-- (--)
Prev Close
$225.74
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
128
52-wk High
$225.76
52-wk Low
$166.15

LZAGF.PK

Chart for LZAGF.PK

About

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a... (more)

Overall

Beta: 1.00
Market Cap(Mil.): CHF15,869.29
Shares Outstanding(Mil.): 74.47
Dividend: 2.55
Yield (%): 1.20

Financials

  LZAGF.PK Industry Sector
P/E (TTM): 40.31 214.05 15.73
EPS (TTM): 5.29 -- --
ROI: 6.10 -7.97 -8.37
ROE: 13.41 -9.29 -7.93

BRIEF-Lonza says received regulatory approval for Capsugel acquisition

* Says lonza has received all regulatory approvals to move forward with acquisition of Capsugel

Jun 27 2017

Exclusive: GTCR, Carlyle in talks to acquire Albany Molecular Research - sources

Buyout firms GTCR LLC and Carlyle Group LP are in talks to team up and jointly acquire U.S. contract drug manufacturer and researcher Albany Molecular Research Inc , people familiar with the matter said on Monday.

Jun 05 2017

BRIEF-Lonza aims to raise 2.25 billion Sfr with new rights offering

* Says determined the final terms of the capital increase by way of a rights offering

Apr 25 2017

EU mergers and takeovers (April 24)

BRUSSELS, April 24 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Apr 24 2017

EU mergers and takeovers (April 10)

BRUSSELS, April 10 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Apr 10 2017

EU mergers and takeovers (April 6)

BRUSSELS, April 6 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Apr 06 2017

REFILE-EU mergers and takeovers (April 4)

BRUSSELS, April 4 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Apr 04 2017

EU mergers and takeovers (March 31)

BRUSSELS, March 31 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Mar 31 2017

EU mergers and takeovers (March 30)

BRUSSELS, March 30 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Mar 30 2017

Lonza to seek shareholder sign-off on 2.3 billion Sfr rights issue

ZURICH Lonza Group AG will ask shareholders at next month's annual general meeting for permission to issue up to 2.3 billion Swiss francs ($2.3 billion) in new shares to finance its acquisition of U.S. capsule maker Capsugel, the Swiss pharmaceutical supplier said on Thursday.

Mar 30 2017

Earnings vs. Estimates